Registered entities
Vir Biotechnology, Inc.
Reg. No. 812730369United States
Vir Biotechnology International GmbH
Reg. No. 1554170Switzerland
Social engagement
Social engagement: 39.2K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Arch Venture Partners, Gates.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 1 | 7% |
| Accelerator & incubator | 2 | 14% |
| Other / undisclosed | 3 | 21% |
Hiring activity
Hires periodically
4 roles tracked across 3 of the last 12 months
3 Mar 2026 · Associate Director, Clinical Operations · San Francisco
4 Dec 2025 · Vice President, Medical Affairs · San Francisco
1 Oct 2025 · Senior Executive Assistant-CEO · San Francisco
6 Sep 2025 · Director, Regulatory Writing (Temporary) San Francisco, California, United States · San Francisco
5 Sep 2025 · Director, Regulatory Writing (Temporary) San Francisco, California, United State · San Francisco
Based on job postings tracked across public sources.
Recent activity
24 Jun 2026
Event
8th T-Cell Engager Therapeutics Summit
22 Jun 2026
Event
BIO2026
18 Jun 2026
Event
BIO2026